Halozyme Therapeutics shares owned by Advent Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Advent Capital Management
from 13F filings
Historical chart of Advent Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Advent Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Advent Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $20M | 20M | 1.01 |
| 2023-09-30 | $5.7M | 6.8M | 0.85 |
| 2023-06-30 | $4.8M | 5.7M | 0.84 |
| 2023-03-31 | $3.7M | 4.3M | 0.85 |
| 2022-12-31 | $17M | 17M | 0.97 |
| 2022-09-30 | $25M | 30M | 0.85 |
| 2022-06-30 | $26M | 29M | 0.89 |
| 2022-03-31 | $25M | 29M | 0.88 |